Nutrien Ltd. (NYSE:NTR) ranks among the most profitable Canadian Stocks to buy now. On March 13, Jefferies upgraded Nutrien Ltd. (NYSE:NTR) to Buy from Hold, raising its price target to $96 from $74. The revised price objective is 7.5x 2027 estimated EBITDA, compared to a five-year average of 6.6x. Jefferies expects $7.0 billion in EBITDA in 2026 and $7.3 billion the following year. In addition, on February 20, BMO Capital boosted Nutrien Ltd. (NYSE:NTR)’s price target to $85 from $75, retaining an Outpe ...

Core Viewpoint - Nutrien's recent earnings report showed mixed results, with profits significantly increasing year-over-year but missing earnings estimates, leading to questions about future performance [2][11]. Financial Performance - Nutrien reported profits of $580 million or $1.18 per share for Q4 2025, a substantial increase from $118 million or 23 cents in the same quarter last year [2]. - Adjusted earnings per share were 83 cents, up from 31 cents a year ago, but fell short of the Zacks Consensus Estimate of 87 cents [2]. - Sales rose approximately 5% year-over-year to $5,340 million, exceeding the Zacks Consensus Estimate of $5,207.3 million [3]. Segment Highlights - Nutrien Ag Solutions (Retail) segment sales decreased by 1% year-over-year to $3,144 million, impacted by lower sales volumes and demand for phosphate, although it surpassed estimates [4]. - The Potash division saw a 37% year-over-year increase in sales to $736 million, but this was below the estimate of $857.9 million [5]. - The Nitrogen segment reported sales of $1,093 million, an 11% increase year-over-year, exceeding the estimate of $657.6 million [6]. - The Phosphate segment generated sales of $483 million, up around 17% year-over-year, surpassing the estimate of $288.1 million [6]. Financial Position - At the end of the quarter, Nutrien had cash and cash equivalents of $701 million, down approximately 18% year-over-year, while long-term debt increased by 5.3% to $9,350 million [7]. - Cash provided from operating activities was $2,977 million for the reported quarter [7]. Outlook - Nutrien projects retail adjusted EBITDA for 2026 to be between $1.75 billion and $1.95 billion, indicating high-single digit growth in proprietary products gross margins and mid-single digit increases in North American crop nutrient sales volumes [8]. - Expected sales volumes for Potash are 14.1–14.8 million tons, Nitrogen at 9.2–9.7 million tons, and Phosphate at 2.4–2.6 million tons [9]. - Capital expenditures are projected at $2–$2.1 billion, including $400 million for growth investments [10]. Analyst Sentiment - Analysts have not made any earnings estimate revisions in the last two months, indicating a period of stability in expectations [11]. - Nutrien holds a Zacks Rank 3 (Hold), suggesting an expectation of an in-line return from the stock in the coming months [13]. VGM Scores - Nutrien has a strong Growth Score of A and a Value Score of A, placing it in the top quintile for investment strategies, although it lags slightly in Momentum with a score of B [12].

Core Insights - The Iran war is causing an oil shock, with Brent crude oil prices around $105 per barrel and US West Texas Intermediate at approximately $99.50 per barrel, both up over 70% this year [1] - This oil shock is more concentrated in the energy sector compared to the broader supply chain crisis and inflation surge seen in 2021 and 2022 [2] Economic Impact - Goldman Sachs estimates that the surge in oil prices could reduce global GDP by about 0.3% and increase headline inflation by roughly 0.5 to 0.6 percentage points over the next year [3] - The bank has revised its global growth forecast down to 2.6% from 2.9% and expects headline inflation to be 2.9% on a fourth-quarter basis [3] Trade Dynamics - Global trade exposure to the Middle East is limited outside of oil and gas, with non-energy trade with Gulf economies accounting for only about 1% of global trade [4] - Comparatively, post-pandemic disruptions in China and East Asia affected over 20% of global trade, indicating that the supply chain disruptions from the Iran war will be much more limited [5] Industry-Specific Risks - Inputs like sulfur, nitrogen, and ammonia, while important for agricultural productivity, are not critical chokepoints for global manufacturing and could be rationed if necessary [6] - Methanol, a chemical used in various industries, poses a potential risk as Iran accounts for nearly one-fifth of global production capacity, which could impact downstream markets [7] Shipping and Freight Costs - Shipping data indicates that non-tanker ocean freight costs have decreased since the onset of the war, while the rise in airfreight costs would contribute less than 5 basis points to global inflation [8]

Core Viewpoint - Fertilizer stocks are experiencing a rise due to concerns over supply disruptions caused by the ongoing closure of the Strait of Hormuz, a vital route for global fertilizer trade [1][2]. Group 1: Market Impact - The conflict in the Middle East has led to shipping disruptions through the Strait of Hormuz, which is critical for the transportation of fertilizer products [2][3]. - Fertilizer prices have increased as exports from key producers in the region face potential constraints, positively impacting the stock prices of companies in the sector [4]. Group 2: Stock Performance - As of the latest data, CF Industries' shares are up 7.30% at $128.90, Nutrien's shares are up 6.72% at $84.64, and Mosaic's shares are up 4.67% at $30.51 [5].

核心观点 Nutrien Ltd. has received approval to initiate a normal course issuer bid to repurchase up to 5% of its outstanding common shares, which aligns with its strategy to return capital to shareholders while maintaining a positive outlook for 2026 retail adjusted EBITDA and sales volumes in the fertilizer sector [1][2][4][8] 分组1: 公司动态 - Nutrien has been approved by the Toronto Stock Exchange to repurchase up to 5% of its issued and outstanding common shares, allowing for the repurchase of approximately 24,057,066 shares [1][8] - The normal course issuer bid (NCIB) is set to begin on March 3, 2026, with daily purchases limited to 25% of the average daily trading volume [3] - Nutrien missed fourth-quarter 2025 earnings but exceeded sales estimates, projecting retail adjusted EBITDA for 2026 to be between $1.75 billion and $1.95 billion [4][8] 分组2: 行业前景 - The fertilizer industry is seeing positive trends, with Nutrien forecasting potash sales volumes for 2026 to be between 14.1 million tons and 14.8 million tons [4][8] - Other industry players like Mosaic Company and CF Industries are also projecting strong sales volumes and a positive nitrogen outlook, indicating robust demand in the fertilizer market [5][6] - Intrepid Potash reported a 15% increase in potash sales volumes, driven by improved production and market fundamentals [7]

Core Thesis - Nutrien Ltd. is positioned favorably in the fertilizer market due to strong organic growth driven by rising demand and constrained supply, which enhances its pricing power [2][4]. Company Overview - Nutrien Ltd. is the world's largest fertilizer company by capacity, formed in 2018 through the merger of PotashCorp and Agrium, operating a vertically integrated model from raw material mining to direct sales to farmers [1]. - The company generates revenue from four segments: Potash, Nitrogen, Phosphate, and Retail through Nutrien Ag Solutions, which operates over 1,500 farm retail locations [1]. Market Dynamics - The market fundamentals are supportive, with low global channel inventories, particularly in China, where port inventories have decreased by over 1 million tons year-over-year [3]. - Limited new capacity additions are expected in 2026 due to project delays, which will maintain a tight supply-demand balance in the nitrogen market [4]. Financial Performance - Nutrien has delivered structural earnings growth through record upstream fertilizer volumes and improved operational reliability, leading to a second upward revision of its 2025 potash sales guidance [2]. - The stock trades at a relatively low valuation, with trailing and forward P/E ratios of 21.49 and 11.85 respectively, reflecting past revenue declines and underappreciation of defensive assets [1][4]. Shareholder Returns - Nutrien offers a ~4% dividend yield and engages in share buybacks, enhancing total shareholder return and providing a compelling opportunity for long-term investors [5].

Core Insights - Linde plc is a leading global industrial gases company with a market capitalization of $232.63 billion, specializing in the manufacturing and distribution of oxygen, nitrogen, and hydrogen for various industries [1] Financial Performance - Linde's shares reached a 52-week high of $504.49 on February 24, with a 23.6% increase over the past three months, compared to a 2.8% gain in the S&P 500 Index during the same period [2] - Over the past 52 weeks, Linde's stock gained 9.9%, underperforming the S&P 500 Index's 15.2% gains, but is up 18.2% year-to-date (YTD) [3] - For the fourth quarter of fiscal 2025, Linde's sales increased 6% year-over-year (YOY) to $8.76 billion, with a 3% growth in underlying sales [4] Segment Performance - In the Americas segment, sales grew by 8% year-over-year to $3.88 billion, driven by a 3% increase in pricing and a 1% increase in volumes, particularly in the electronics end market [4] Growth Prospects - Analysts expect Linde's diluted EPS to climb 8.1% YOY to $4.27 for the current quarter, with projections of 8.1% annual growth to $17.79 for fiscal 2026 and 9% growth to $19.39 in fiscal 2027 [5] Competitive Positioning - Compared to Air Products and Chemicals, Inc., which declined 9.7% over the past 52 weeks but gained 13.1% YTD, Linde has been the clear outperformer [6]

Forward Looking Statements Investor Presentation February 2026 Forward-looking statements Certain statements and other information included in this presentation, including under the "Market Outlook" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "i ...

Core Insights - Nutrien reported strong financial performance in 2025, with adjusted EBITDA of $6.05 billion, a 13% increase from the previous year, and record fertilizer sales volumes of 27.5 million tons [4][8] - The company emphasized cost discipline and capital allocation priorities for 2026, focusing on free cash flow generation and shareholder returns [5][21] Phosphate - The phosphate operating rate averaged 87% in the second half of 2025, with Nutrien delivering within guidance despite lower North American demand in Q4 [1] - Nutrien expects phosphate sales volumes of 2.4–2.6 million tons, with most growth projected in the first half of 2026 [16] Nitrogen - Nitrogen sales volumes increased to 10.9 million tons, with ammonia operating rates improving by four percentage points due to reliability initiatives [2] - Management guided nitrogen sales volumes of 9.2–9.7 million tons for 2026, assuming no production from Trinidad and New Madrid [15] Potash - Nutrien raised potash sales volume guidance twice in 2025, achieving 49% mine automation and controllable cash costs averaging $58 per ton [3] - The company expects potash sales guidance of 14.1–14.8 million tons for 2026, with benchmark prices projected to be approximately 20% higher year-over-year [7][12] Financial Performance - Nutrien generated about $900 million from divestitures in 2025, using proceeds to reduce short-term debt by over $600 million and increase cash returns to shareholders [6][10] - The company trimmed capital expenditures to about $2.0 billion, below the $2.2–$2.3 billion target set during the Investor Day [8][21] Strategic Reviews - Nutrien launched strategic reviews for its phosphate business and parts of its Brazilian operations, with potential outcomes ranging from operational revisions to sales [17][20] - The Trinidad nitrogen operations faced challenges due to gas availability and pricing, leading to a controlled shutdown [18][19] Capital Allocation - Nutrien's capital allocation priorities for 2026 include maintaining capital expenditures at $2.0–$2.1 billion and continuing dividend growth, marking the eighth consecutive year of increases [21][22] - The company authorized share repurchases of up to 5% of outstanding shares, with a consistent repurchase pace of approximately $50 million per month [22]

Core Viewpoint - Air Liquide reported a recurring operating income of 5.58 billion euros for 2025, slightly exceeding analyst expectations of 5.56 billion euros, driven by efficiencies, pricing management, and dynamic asset portfolio management [1][1][1] Financial Performance - The recurring operating profit increased from 5.39 billion euros in 2024 to 5.58 billion euros in 2025, reflecting a positive growth trend [1][1][1] - Analysts from Vara Research had anticipated a sales figure of 5.56 billion euros on average, indicating that Air Liquide's performance was above market expectations [1][1][1] Business Operations - The company specializes in supplying industrial gases such as oxygen, nitrogen, and hydrogen to various sectors, including factories and hospitals, highlighting its critical role in industrial operations [1][1][1] - The growth in operating income is attributed to effective pricing strategies particularly in the Industrial Merchant unit, showcasing the company's ability to manage costs and optimize revenue streams [1][1][1]